Katherine Ruffner

Katherine Ruffner

Inga fler pågående positioner
Health Technology
Consumer Services

Profil

Katherine L.
Ruffner
worked as a Senior Director of Clinical Development at Seagen Inc. She was the Vice President of Clinical Development at CTI BioPharma Corp from 2008 to 2019.
Prior to that, she was an Assistant Professor at Vanderbilt University from 2002 to 2007.
She also worked as the Vice President of Clinical Development at ALX Oncology Holdings, Inc. from 2020 to 2021 and as the Chief Medical Officer at Cardiff Oncology, Inc. in 2021 to 2022.
Ruffner received her undergraduate degree from Duke University and her graduate degree from the University of Tennessee.

Tidigare kända positioner av Katherine Ruffner

FöretagPositionSlut
CARDIFF ONCOLOGY, INC. Teknisk/Vetenskaplig/F&U Direktör 2022-04-22
ALX ONCOLOGY HOLDINGS INC. Företagsledare/Principal 2021-05-01
CTI BIOPHARMA CORP. Teknisk/Vetenskaplig/F&U Direktör 2019-02-01
Företagsledare/Principal 2007-01-01
SEAGEN INC. Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i Katherine Ruffners erfarenhet

Katherine Ruffners utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

81

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Katherine Ruffner